The page lists 85 projects related to the topic "fibrosis".
# | |||
---|---|---|---|
1 | PRO-CF-MED | Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication | 2015 |
2 | METASPACE | Bioinformatics for spatial metabolomics | 2015 |
3 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
4 | BETA3_LVH | A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease | 2015 |
5 | BREATHE | Biochemically modified messenger RNA encoding nucleases for in vivo gene correction of severe inherited lung diseases | 2015 |
6 | MyCyFAPP | Innovative approach for self-management and social welfare of Cystic Fibrosis patients in Europe: development, validation and implementation of a telematics tool. | 2015 |
7 | GLYCO-TOOLS | Bio-Inspired Tools for Glycoscience | 2015 |
8 | ENABLE | Establishment of a Neutrophil elastase Activity home test for the Better management and treatment of Lung Exacerbations | 2014 |
9 | GelSwimming | Bacterial motion in polymer solutions and biogels | 2016 |
10 | CARDI-ACHE | The cardiovascular consequences of endurance exercise | 2015 |
11 | COMMANDEER | COMMANDEER: Disrupting microbial resistance using rationally designed signalling molecules | 2015 |
12 | GDA in staphylococci | Gen Duplication and Amplification in Staphylococcal populations | 2016 |
13 | TARGEPILIVER | Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. | 2015 |
14 | REZONABLE | Regeneration and zonation by ZEB2 of Liver Endothelium | 2016 |
15 | AFIBROTIC | Atrial Fibrillation, Fibrosis and Rotors: New Insights from Imaging and Computational Modeling | 2015 |
16 | Subpopulations | Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy | 2016 |
17 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
18 | InCisive | creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease | 2016 |
19 | 2-NanoSi | Ratiometric FRET Based Nanosensors for Trypsin Related Human Recessive Diseases | 2015 |
20 | HBV1 | Innate immune responses to human hepatotropic viral infections | 2015 |
21 | PULTAR | Delivery of PULmonary Therapeutics through TARgetted Delivery using Phononics | 2015 |
22 | STARS | Strategies Targeting Thyroid Hormone in Athrophy Related Syndromes | 2015 |
23 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
24 | HEPCIR | Cell circuits as targets and biomarkers for liver disease and cancer prevention | 2016 |
25 | TAT-CF | Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters | 2016 |
26 | GALAXY | GALAXY: Gut-and-liver axis in alcoholic liver fibrosis | 2016 |
27 | MIRASYS | The diagnostic potential of miRNAs for early diagnosis of Systemic Sclerosis | 2016 |
28 | Gene2Skin | Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies | 2015 |
29 | DeMILI | NON INVASIVE DIAGNOSTIC TEST SERVICE FOR “NON ALCOHOLIC FATTY LIVER DISEASE” MANAGEMENT | 2016 |
30 | CollBioImag | Development of a cell-based system for high-throughput screening of antifibrotics | 2016 |
31 | ENDYVE | ENgineering DYnamic ViscoElasticity to study cell response | 2016 |
32 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
33 | GENDER-CF | Gender-related differences in expression of microRNAs in cystic fibrosis | 2017 |
34 | CureCKDHeart | Targeting perivascular myofibroblast progenitors to treat cardiac fibrosis and heart failure in chronic kidney disease | 2016 |
35 | NANOZ-ONIC | Bio-inspired electrONIC NOSE interfacing olfactory electrical biosensors and carbon NANOtubes | 2016 |
36 | CF_struct | High-Resolution X-ray Structures of Full-Length Cystic Fibrosis Transmembrane Conductance Regulator | 2016 |
37 | Niche Fibrosis | Identification of regulatory signals from vascular niche in alveolar regeneration and pulmonary fibrosis | 2016 |
38 | DMD2CURE | Correction of duplications in the DMD gene by a CRISPR/Cas9 approach | 2017 |
39 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
40 | Relieve-Chol | Reprogramming cell identity to develop new therapies against Cholangiopathies | 2016 |
41 | RespeCT | Respiratory Disease Screening with Dark-Field Computed Tomography | 2016 |
42 | Neurofibres | Biofunctionalised Electroconducting Microfibres for the Treatment of Spinal Cord Injury | 2017 |
43 | SEMA3C | Genetic dissection of the SEMA3C/Neuropilin 1 signalling pathway in Chronic Kidney Disease progression | 2016 |
44 | EXNADMINA | EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease | 2016 |
45 | SWEETBULLETS | Sweet Theranostics in Bitter Infections - Seek and Destroy | 2017 |
46 | MUC2GO | THE ROLE OF MUCINS AND MUCUS IN THE DISEASES CYSTIC FIBROSIS, CELIAC DISEASE, AND ULCERATIVE COLITIS | 2016 |
47 | FiTTeR | Developing a Fibrosis Targeting and Tissue Reparative (FiTTeR) Therapy for the Infarcted Myocardium via an Injectable Functionalized Extracellular Matrix Hydrogel | 2017 |
48 | Glyco-Platforms | Novel smart glyco-nanomaterials as targeted therapeutics. | 2017 |
49 | CFZEBRA | Balancing the immune response in cystic fibrosis: using zebrafish models of infection and inflammation to uncover new therapeutic approaches | 2017 |
50 | PRELICAN | Treatment of liver disease and cancer prevention | 2017 |
51 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
52 | deFIBER | Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment | 2018 |
53 | LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis | 2017 |
54 | New Chol | Development of New therapies against cholangiopathies. | 2017 |
55 | HIT-CF | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | 2018 |
56 | OligoGpivotalCF | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | 2018 |
57 | N-IF | The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies | 2017 |
58 | IRONAGE | Iron as a driver of fibrosis and regeneration | 2018 |
59 | ROCKSOFT | Rho GTPase cross-talk with syndecan-4 regulates pro-fibrotic mechanotransduction in the heart | 2019 |
60 | CaLecLig | Calcium-dependent Lectins in Human Pathogenic Infections: From Atomistic Understanding to Ligand Design | 2018 |
61 | EnCAge | Progeria models to study endothelial cell ageing: implications for organ regeneration and fibrosis | 2020 |
62 | COAGULANT | CK2-dependent cytoskeletal regulation and molecular signaling of Neutrophil Extracellular Trap (NET) formation | 2018 |
63 | FIBROSIS | Fibroproliferative Invasive Fibroblasts in Idiopathic Pulmonary Fibrosis | 2018 |
64 | ASSYSt | A reliable CXCL4 biomarker assay to improve diagnosis and treatment of Systemic Sclerosis | 2018 |
65 | LIFT | Liquid Foam Therapy (LIFT) for Acute Respiratory Distress Syndrome (ARDS) | 2018 |
66 | FIBROHALT | Advancing a novel peptide-based therapeutic for pancreatic cancer | 2018 |
67 | EPIORGABOLISM | Diabetic nephropathy modelling in hESC-derived 3D kidney organoids | 2019 |
68 | TransReg | Transgenerational epigenetic inheritance of cardiac regenerative capacity in the zebrafish | 2019 |
69 | ProMiDis | A unified drug discovery platform for protein misfolding diseases | 2019 |
70 | HepEDOT | Conductive, self-doping and biodegradable oligoEDOT-heparin biomaterial for improved electromechanical coupling, cardiac cell retention and delivery of paracrine factors | 2019 |
71 | DIE_CKD | Deciphering intrarenal communication to unvail mechanisms of chronic kidney diseases | 2019 |
72 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
73 | RespiriNTM | Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs | 2019 |
74 | MechanoGPER | Development of GPER agonists as a novel therapeutic option for pancreatic cancer | 2019 |
75 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
76 | CYPNASH | Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis | 2019 |
77 | LIGHT4LUNGS | Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections | 2019 |
78 | POWER-PATCH | Self-Powered Skin Patch for Cystic Fibrosis Diagnosis | 2020 |
79 | RheoCare | Rheological Monitoring of Chronic Respiratory Diseases | 2019 |
80 | REMEDIA | Impact of exposome on the course of lung diseases | 2020 |
81 | LiverScreen | Screening for liver fibrosis - population-based study across European countries | 2020 |
82 | DRTB-HDT | STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL | 2020 |
83 | ICaRMuSs | Intragranullar calcium regulation of mucin secretion and sorting. | 2020 |
84 | MRTFSen | MRTF/SRF signalling in regulation of cell senescence and melanoma progression | 2020 |
85 | HTS MALDI-TOF MDD | MALDI-TOF mass spectrometry metabolite screening assays for drug discovery in human disease | 2020 |